Cesaretti JA - Search Results

1

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.

Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, Green S, Haffty B, Drumea K, Leitzin L, Kuten A, Azria D, Ozsahin M, Overgaard J, Andreassen CN, Trop CS, Park J, Rosenstein BS. Ho AY, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):646-55. doi: 10.1016/j.ijrobp.2006.03.006. Int J Radiat Oncol Biol Phys. 2006. PMID: 16751059

2

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Stock RG, Stone NN, Cesaretti JA. Stock RG, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):448-53. doi: 10.1016/s0360-3016(02)04470-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738319

3

Urinary symptom flare following I-125 prostate brachytherapy.

Cesaretti JA, Stone NN, Stock RG. Cesaretti JA, et al. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1085-92. doi: 10.1016/s0360-3016(03)00210-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12829146

4

Combined modality treatment in the management of high-risk prostate cancer.

Stock RG, Cahlon O, Cesaretti JA, Kollmeier MA, Stone NN. Stock RG, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1352-9. doi: 10.1016/j.ijrobp.2004.01.023. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275720 Clinical Trial.

5

Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.

Cesaretti JA, Stone NN, Stock RG. Cesaretti JA, et al. Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):648-53. doi: 10.1016/j.ijrobp.2004.05.070. Int J Radiat Oncol Biol Phys. 2004. PMID: 15380602

6

ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. Cesaretti JA, et al. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):196-202. doi: 10.1016/j.ijrobp.2004.09.031. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629612

7

Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Stock RG, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):527-33. doi: 10.1016/j.ijrobp.2005.07.981. Epub 2005 Oct 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16242258

8

Disease-specific survival following the brachytherapy management of prostate cancer.

Stock RG, Cesaretti JA, Stone NN. Stock RG, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):810-6. doi: 10.1016/j.ijrobp.2005.09.005. Epub 2005 Nov 23. Int J Radiat Oncol Biol Phys. 2006. PMID: 16309852

9

ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.

Andreassen CN, Overgaard J, Alsner J, Overgaard M, Herskind C, Cesaretti JA, Atencio DP, Green S, Formenti SC, Stock RG, Rosenstein BS. Andreassen CN, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):776-83. doi: 10.1016/j.ijrobp.2005.09.014. Epub 2005 Dec 9. Int J Radiat Oncol Biol Phys. 2006. PMID: 16338099

10

Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.

Peters CA, Cesaretti JA, Stone NN, Stock RG. Peters CA, et al. Among authors: cesaretti ja. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):424-9. doi: 10.1016/j.ijrobp.2006.05.027. Epub 2006 Aug 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16887295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters